Dr. Sergey Gazenko is an internationally respected Microbiologist and Molecular Biologist with more than 20 years of experience in research and various corporate research positions. His work over the years has contributed to several products developed. Dr. Gazenko studied and received his Masters at Moscow State Pedagogical Institute in New York City and received his Doctorate from The Institute of Applied Biochemistry, Moscow, Russia.

Dr. Gazenko's work will assist in the increased efficacy of NanoLogix's hydrogen generating system and determine conclusively the method in which NanoLogix's technologies interface and compliment current alternative fuel systems such as, methane production. Lab models and research will be necessary to document improvements in the overall methodologies and contribute to further patents.

NanoLogix is led by Mitchell S. Felder M.D., who has been a co-author on fifteen of NanoLogix's patents and has worked in its clinical medical efforts. Dr. Felder has assisted in the prior investment banking, publicity and marketing efforts of the Company. Dr. Felder attended the University of Pennsylvania and received a B.A. degree in sociology in 1975. He is a diplomate and member of the American Academy of Neurology. Dr. Felder then received his Doctor of Medicine (M.D.) degree from the University of Rome, Italy in 1983. Dr. Felder is a diplomate in the field of neurology. Dr. Felder is joined by David C. McClelland Sr. who serves as the Company's President and CFO. Mr. McClelland has over 15 years experience in technology and business development taking several companies through development of intellectual property to revenues in sectors such as medical, software, biotechnology, commercial products, etc. He holds a Bachelor's Degree in Mechanical Engineering of Technology from Gannon University, Erie, Pennsylvania and several degree credits from Penn State University in business, plastics and engineering. Additionally, Mr. McClelland has ten years experience teaching manufacturing and management courses with area colleges. Mr. McClelland is an apprentice graduate of General Electric Company in 1976.

Mitchell S. Felder M.D., CEO of NanoLogix, commented, "We are very pleased to have Dr. Gazenko. NanoLogix has greatly strengthened the depth of its hydrogen bioreactor team by having such an accomplished microbiologist on board."